Stallings RL - Search Results

1

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.

Welch C, Chen Y, Stallings RL. Welch C, et al. Among authors: stallings rl. Oncogene. 2007 Jul 26;26(34):5017-22. doi: 10.1038/sj.onc.1210293. Epub 2007 Feb 12. Oncogene. 2007. PMID: 17297439

2

Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.

Chen Y, Stallings RL. Chen Y, et al. Among authors: stallings rl. Cancer Res. 2007 Feb 1;67(3):976-83. doi: 10.1158/0008-5472.CAN-06-3667. Cancer Res. 2007. PMID: 17283129

3

High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.

Nair PN, McArdle L, Cornell J, Cohn SL, Stallings RL. Nair PN, et al. Among authors: stallings rl. Cancer Genet Cytogenet. 2007 Apr 15;174(2):100-10. doi: 10.1016/j.cancergencyto.2006.11.017. Cancer Genet Cytogenet. 2007. PMID: 17452250

4

High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma.

Stallings RL, Nair P, Maris JM, Catchpoole D, McDermott M, O'Meara A, Breatnach F. Stallings RL, et al. Cancer Res. 2006 Apr 1;66(7):3673-80. doi: 10.1158/0008-5472.CAN-05-4154. Cancer Res. 2006. PMID: 16585193

5

MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.

Tivnan A, Tracey L, Buckley PG, Alcock LC, Davidoff AM, Stallings RL. Tivnan A, et al. Among authors: stallings rl. BMC Cancer. 2011 Jan 25;11:33. doi: 10.1186/1471-2407-11-33. BMC Cancer. 2011. PMID: 21266077 Free PMC article.

6

MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma.

Bray I, Tivnan A, Bryan K, Foley NH, Watters KM, Tracey L, Davidoff AM, Stallings RL. Bray I, et al. Among authors: stallings rl. Cancer Lett. 2011 Apr 1;303(1):56-64. doi: 10.1016/j.canlet.2011.01.016. Cancer Lett. 2011. PMID: 21310526 Free PMC article.

7

MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A.

Althoff K, Beckers A, Odersky A, Mestdagh P, Köster J, Bray IM, Bryan K, Vandesompele J, Speleman F, Stallings RL, Schramm A, Eggert A, Sprüssel A, Schulte JH. Althoff K, et al. Among authors: stallings rl. Int J Cancer. 2013 Sep 1;133(5):1064-73. doi: 10.1002/ijc.28091. Epub 2013 Mar 7. Int J Cancer. 2013. PMID: 23400681 Free article.

8

Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs.

Das S, Bryan K, Buckley PG, Piskareva O, Bray IM, Foley N, Ryan J, Lynch J, Creevey L, Fay J, Prenter S, Koster J, van Sluis P, Versteeg R, Eggert A, Schulte JH, Schramm A, Mestdagh P, Vandesompele J, Speleman F, Stallings RL. Das S, et al. Among authors: stallings rl. Oncogene. 2013 Jun 13;32(24):2927-36. doi: 10.1038/onc.2012.311. Epub 2012 Jul 16. Oncogene. 2013. PMID: 22797059 Free PMC article.

9

Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma.

Santo EE, Ebus ME, Koster J, Schulte JH, Lakeman A, van Sluis P, Vermeulen J, Gisselsson D, Øra I, Lindner S, Buckley PG, Stallings RL, Vandesompele J, Eggert A, Caron HN, Versteeg R, Molenaar JJ. Santo EE, et al. Among authors: stallings rl. Oncogene. 2012 Mar 22;31(12):1571-81. doi: 10.1038/onc.2011.344. Epub 2011 Aug 22. Oncogene. 2012. PMID: 21860421

10

The origin of chromosome imbalances in neuroblastoma.

Stallings RL, Yoon K, Kwek S, Ko D. Stallings RL, et al. Cancer Genet Cytogenet. 2007 Jul 1;176(1):28-34. doi: 10.1016/j.cancergencyto.2007.02.014. Cancer Genet Cytogenet. 2007. PMID: 17574961

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page